1 min listen
Fibrobiologics walks the unconventional financing path
Fibrobiologics walks the unconventional financing path
ratings:
Length:
18 minutes
Released:
May 15, 2024
Format:
Podcast episode
Description
A non-traditional route for financing has been the path to success for Fibrobiologics Inc. In the newest BioWorld Insider podcast, CEO Pete O’Heeron offers insight into the company’s unusual path to a Nasdaq listing in January. SPACs, reverse mergers and traditional IPOs weren’t attractive enough for Fibrobiologics’ management or board, so they decided to go public through a direct listing with no banks as underwriters. It took about seven months to get the company ready for its listing, an around-the-clock effort that O’Heeron said was worth the effort. “We couldn’t be more happy with the outcome,” he said.
Released:
May 15, 2024
Format:
Podcast episode
Titles in the series (38)
The BioWorld Insider Podcast - trailer by The BioWorld Insider Podcast